Global Epinephrine Auto-Injectors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Epinephrine Auto-Injectors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.

According to our (Global Info Research) latest study, the global Epinephrine Auto-Injectors market size was valued at US$ 1401 million in 2023 and is forecast to a readjusted size of USD 1967 million by 2030 with a CAGR of 5.0% during review period.

Global core Epinephrine Auto-Injectors manufacturers include Viatris, Teva Pharmaceutica etc. The top 1 company hold a share about 42%. North America is the largest market, with a share about 75%, followed by Europe which shares about 20%. In terms of product, 0.3 mg is the largest segment, with a share about 80%. And in terms of application, the largest end user is over 12 years patients.

This report is a detailed and comprehensive analysis for global Epinephrine Auto-Injectors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Epinephrine Auto-Injectors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2019-2030

Global Epinephrine Auto-Injectors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2019-2030

Global Epinephrine Auto-Injectors market size and forecasts, by Type and by End User, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2019-2030

Global Epinephrine Auto-Injectors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/K Units), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Epinephrine Auto-Injectors

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Epinephrine Auto-Injectors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Viatris, Teva Pharmaceutica, ALK Abello, Amneal Pharmaceuticals, Kaléo, Bioprojet Pharma, Bausch Health, Novartis Sandoz, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Epinephrine Auto-Injectors market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
0.3 mg
0.15 mg
0.5 mg
0.1 mg

Market segment by End User
Under 6 Years Patients
6 to 12 Years Patients
Over 12 Years Patients

Major players covered
Viatris
Teva Pharmaceutica
ALK Abello
Amneal Pharmaceuticals
Kaléo
Bioprojet Pharma
Bausch Health
Novartis Sandoz

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Epinephrine Auto-Injectors product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Epinephrine Auto-Injectors, with price, sales quantity, revenue, and global market share of Epinephrine Auto-Injectors from 2019 to 2024.

Chapter 3, the Epinephrine Auto-Injectors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Epinephrine Auto-Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by End User, with sales market share and growth rate by Type, by End User, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Epinephrine Auto-Injectors market forecast, by regions, by Type, and by End User, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Epinephrine Auto-Injectors.

Chapter 14 and 15, to describe Epinephrine Auto-Injectors sales channel, distributors, customers, research findings and conclusion.